(3R,4S)-3-ETHYL-4-(3H-IMIDAZO(1,2-A)PYRROLO(2,3-E)PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)-1-PYRROLIDINECARBOXAMIDE
UNII BQ9E9BDF22
Substance Identification & Data
This profile provides standardized clinical and technical data for (3r,4s)-3-ethyl-4-(3h-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BQ9E9BDF22.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1310726-59-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C17H19F3N6O WYQFJHHDOKWSHR-WDEREUQCSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (3r,4s)-3-ethyl-4-(3h-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.